Galen/Atlantica serves developers of breakthrough medicines and diagnostics through cross-functional strategic, regulatory, commercial and public affairs advice. We enable advances in science and technology to deliver patient benefits and commercial returns while shaping guardrails around the governance of frontier technologies such as AI and gene manipulation.